Back to 
HighTower Advisors, LLC
HighTower Advisors, LLC
CHRS
Showing 0 of 13 quarters
Position history for HighTower Advisors, LLC's holdings in Coherus Oncology, Inc.
No. HighTower Advisors exited its CHRS (Coherus Oncology) position in Q4 2021. Its Q3 2021 13F listed 11,775 shares worth $189,000. HighTower Advisors already held CHRS in its Q4 2018 13F, the earliest on record, and held it in 12 quarterly 13F filings.
Current Value
—
Current Shares
—
Total Value Change
$0
Total Shares Change
0
No position history available for this security.